News
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...
Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Novo Nordisk filed for approval of an oral, 25-mg formulation of semaglutide “earlier this year,” according to a company spokesperson.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback